Skip to content
Medical Health Aged Care, Research Development

MEDIA RELEASE: Cancer Council ACT announces the 2025 Cancer Research Grant Recipients at Government House

Cancer Council ACT 2 mins read
 

On Thursday 29 May, Her Excellency the Honourable Sam Mostyn AC, Governor-General of the Commonwealth of Australia, and Patron of Cancer Council ACT, hosted a special Australia’s Biggest Morning Tea event at Government House for volunteers, supporters and researchers.  

At the event, Dr. Di Wang and Dr. Olga Zaytseva, both from the Australian National University (ANU), were officially announced as the 2025 Cancer Council ACT Research Grant recipients. 

Dr. Wang received the grant for his project titled "Harnessing RNA-Protein Interactions for the Regulation of Hepatocellular Carcinoma Progression". His project aims to design small molecules to control specific cancer-promoting genes in order to improve therapies for people living with liver cancer. 

“With the support of this grant, we will build on our understanding of these RNA hairpin structures and also investigate the potential of small molecules to bind and stabilise these elements,” said Dr. Wang. 

The hope is that “this will restore their ability to regulate MAT2A through the target mRNA, which plays a key role in hepatocellular carcinoma (HCC) development.”  

“I gratefully acknowledge the support from Cancer Council ACT, which has been instrumental in advancing this research project.” 

Dr. Zaytseva was awarded the grant for her research into "Rational approaches to identify new treatments for primary brain cancer." Her project aims to identify new drugs effective at killing brain cancer cells, by specifically targeting their energy production which is disrupted compared to normal cells. 

"Studying brain cancer cells collected via the ACT Brain Cancer Biobank that closely resemble patient tumours, we will maximise chances that our findings will ultimately inform effective tumour treatments.” 

Dr. Zaytseva’s research is further strengthened by collaboration with the Canberra Hospital, connecting laboratory researchers with the clinicians and creating a direct pipeline from laboratory discoveries to potential clinical applications. 

“We are thrilled to support Dr Wang and Dr Zaytseva’s innovative work, both of which have the potential to lead to meaningful advances in cancer treatment right here in the ACT. This progress is made possible by the generosity of our community and fundraising efforts like Australia’s Biggest Morning Tea,” said Verity Hawkins, CEO of Cancer Council ACT. 

Canberrans are encouraged to host their own Australia’s Biggest Morning Tea events until the end of June.  


Key Facts:

*Cancer Council ACT has awarded two grants of $75,000 to Dr Di Wang and Dr. Olga Zaytseva both from the John Curtin School of Medical Research at the ANU.

*The projects funded include research into liver cancer therapies and identifying effective drugs to combat brain cancer.

*The awards were hosted at Government House by Her Excellency the Honourable Sam Mostyn AC, Governor-General of the Commonwealth of Australia, and Patron of Cancer Council ACT

*Cancer Council relies on community fundraising to fund these research grants, and is encouraging Canberrans to host a Biggest Morning Tea.


About us:

Cancer Council ACT has been advocating for Canberrans living with cancer for more than 50 years across every aspect of cancer prevention, support and research to alleviate the impact of cancer in the community. Learn more about what we do here. 


Contact details:
 

Cancer Council ACT 

[email protected] 

Ph: 02 6257 9999 

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 11/12/2025
  • 14:21
Hepatitis Australia and ASHM

Australia’s leading hepatitis experts reaffirm support for birth-dose hepatitis B vaccination

Australia’s foremost hepatitis researchers and clinicians have released a joint expert statement confirming that Australia’s recommendation remains unchanged: all medically stable newborns who meet the weight threshold should receive their first dose of the hepatitis B vaccine within 24 hours of birth. The statement follows international attention after a U.S. advisory panel recommended reversing its long-standing advice that infants receive the hepatitis B vaccine at birth. Hepatitis Australia CEO Lucy Clynes said parents and healthcare professionals should remain confident in Australia’s long-standing, evidence-based approach. “Australia’s advice has not changed. The hepatitis B birth-dose vaccination is safe, effective and one of…

  • Medical Health Aged Care
  • 11/12/2025
  • 10:10
Royal Australian College of GPs

Commonsense health check decision a win for patients and GPs

The Royal Australian College of General Practitioners (RACGP) has welcomed a Medical Board of Australia (MBA) decision to not introduce mandatory health checks for GPs aged 70 and over. Rather than adding to the already burdensome regulatory environment for GPs, the RACGP has consistently argued that the focus should instead be on supporting doctors’ wellbeing. The MBA had previously proposed introducing general health checks for late-career doctors aged 70 and older to support early detection of concerns but has instead committed to a profession-led approach. RACGP President Dr Michael Wright said the MBA had made the right call. “We are…

  • Contains:
  • Medical Health Aged Care
  • 11/12/2025
  • 07:42
Palliative Care Australia

Australia can relieve hospital ‘bed block’ with palliative care investment

Palliative Care Australia (PCA), the peak body for palliative care in Australia, has injectednew ideasinto the debate on how to relieve “bed block” in…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.